Business
Travere Therapeutics to Report First Quarter 2026 Financial Results
SAN DIEGO, April 27, 2026--Travere Therapeutics, Inc. (Nasdaq: TVTX) today announced it will report first quarter 2026 financial results on Monday, May 4, 2026, after the close of the U.S. financial markets. The Company will host a conference call and webcast to discuss the financial results and provide a general business update at 4:30 p.m. ET.
About this update from Travere Therapeutics, Inc.
[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":1604,"height":352,"url":"https://media.zenfs.com/en/business-wire.com/6ba0b00e1a2826e58d1e5e8b1a7fcf5e"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/SHZEa.lha5C4uQ9xh7Uz4Q--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTIxMQ--/https://media.zenfs.com/en/business-wire.com/6ba0b00e1a2826e58d1e5e8b1a7fcf5e","width":960,"height":211},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/2t62inwQ_DKpKHlDLpmIgw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTI0MDA7aD01MjY-/https://media.zenfs.com/en/business-wire.com/6ba0b00e1a2826e58d1e5e8b1a7fcf5e","width":1200,"height":263}},"lazy":false},{"type":"text","content":"SAN DIEGO, April 27, 2026--(BUSINESS WIRE)--Travere Therapeutics, Inc. (Nasdaq: TVTX) today announced it will report first quarter 2026 financial results on Monday, May 4, 2026, after the close of the U.S. financial markets. The Company will host a conference call and webcast to discuss the financial results and provide a general business update at 4:30 p.m. ET.","length":364,"tagName":"p"},{"type":"text","content":"The webcast and dial-in information can be accessed on the Investor page of Travere’s website at https://ir.travere.com/events-and-presentations. Following the live webcast, an archived version of the call will be available for 30 days on the Company’s website.","length":261,"tagName":"p"},{"type":"text","content":"About Travere Therapeutics","length":26,"tagName":"p"},{"type":"text","content":"At Travere Therapeutics, we are in rare for life. We are a biopharmaceutical company that comes together every day to help patients, families, and caregivers of all backgrounds as they navigate life with a rare disease. On this path, we know the need for treatment options is urgent – that is why our global team works with the rare disease community to identify, develop, and deliver life-changing therapies. In pursuit of this mission, we continuously seek to understand the diverse perspectives of rare patients and to courageously forge new paths to make a difference in their lives and provide hope – today and tomorrow. For more information, visit travere.com.","length":666,"tagName":"p"},{"type":"text","content":"View source version on businesswire.com: https://www.businesswire.com/news/home/20260427119922/en/","lengt...